Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels


Jazz Pharmaceuticals Plc Says For March Quarter, Co. Estimates Revenues $605M-$610M Representing Increase Of About 13% To 14%; Sees Adj. EBITDA $303M-$307M


Benzinga | Apr 20, 2021 09:21AM EDT

Jazz Pharmaceuticals Plc Says For March Quarter, Co. Estimates Revenues $605M-$610M Representing Increase Of About 13% To 14%; Sees Adj. EBITDA $303M-$307M






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC